Today: 29 April 2026
Browse Category

NASDAQ:XCUR 9 December 2025

Biggest Stock Gainers Today (December 9, 2025): AFJK, NCPL, XCUR, ALEX and DBI Lead the After‑Bell Rally

Biggest Stock Gainers Today (December 9, 2025): AFJK, NCPL, XCUR, ALEX and DBI Lead the After‑Bell Rally

Aimei Health Technology shares surged 968% to $85.47 Tuesday after the SPAC extended its merger deadline to January 6, 2026, fueling speculation of a pending deal. The S&P 500 closed down 0.02%, while microcap stocks dominated gains, with Oriental Culture Holding up 321% and Netcapital up 122%. Trading in AFJK exceeded 6 million shares, far above its average.
9 December 2025
··········
Exicure (XCUR) Stock Soars on Burixafor Phase 2 Data: What December 2025 Investors Need to Know

Exicure (XCUR) Stock Soars on Burixafor Phase 2 Data: What December 2025 Investors Need to Know

Exicure shares surged over 100% in pre-market trading December 9 after reporting positive topline Phase 2 results for burixafor in multiple myeloma at the ASH meeting. The trial met its primary endpoint in 17 of 19 patients, with no serious drug-related adverse events. XCUR closed at $5.33 on December 8, up 8.78%, and traded as high as $10.84 pre-market, pushing market cap to around $30–40 million.
9 December 2025
··

Stock Market Today

  • Shore Capital Reaffirms 'House Stock' Rating for Warpaint London Amid Price Target Cut
    April 29, 2026, 3:30 PM EDT. Warpaint London (LON:W7L) saw its 'house stock' rating reaffirmed by Shore Capital Group on Wednesday, despite Berenberg Bank cutting its price target from GBX 510 to GBX 470 with a 'buy' rating. The stock fell 8.3% to GBX 172 on heavy volume, surpassing its average daily trade. With a market cap near £139 million and a P/E ratio of 8.7, Warpaint London posted Q1 earnings of GBX 16.68 per share and a return on equity of 21.3%. The company operates in cosmetics under brands like W7 and Technic, selling internationally. Analysts maintain an average consensus rating of 'Buy' with a target around GBX 455. Investors watched closely as the stock traded below its 50-day average of GBX 215.58 amid mixed analyst signals.

Latest article

Marathon Petroleum Stock Jumps Before Earnings as Refining Margins Put Wall Street on Alert

Marathon Petroleum Stock Jumps Before Earnings as Refining Margins Put Wall Street on Alert

29 April 2026
Marathon Petroleum shares rose 3.2% to $240.05 Wednesday as investors anticipated its May 5 earnings report, following a surge in fuel margins during the first quarter. Phillips 66 and Valero also gained after posting stronger-than-expected results. Marathon’s Robinson refinery in Illinois began planned maintenance in March. U.S. gasoline prices hit $4.18 a gallon, the highest since 2022, according to AAA.
Why MaxLinear Stock Is Surging as AI Data-Center Demand Rewrites the Story

Why MaxLinear Stock Is Surging as AI Data-Center Demand Rewrites the Story

29 April 2026
MaxLinear shares rose about 34% to $69.58 on Wednesday after Loop Capital upgraded the stock and raised its target to $75. The surge followed a first-quarter report showing infrastructure revenue up 136% to become the company’s largest segment. Total revenue climbed 43% to $137.2 million. MaxLinear guided second-quarter revenue to $160–$170 million, citing strong demand for data-center optical products.
FuelCell Energy Stock Jumps As AI Power Bet Gets Fresh Boost From Bloom Energy

FuelCell Energy Stock Jumps As AI Power Bet Gets Fresh Boost From Bloom Energy

29 April 2026
FuelCell Energy shares climbed $2.75 to $12.69 Wednesday, trading on heavy volume after Bloom Energy raised its 2026 outlook and reported a 130% jump in first-quarter revenue to $751.1 million. Bloom shares surged over 23% after announcing its fuel cells would power Oracle’s planned New Mexico AI data center. FuelCell’s first-quarter revenue rose 61% to $30.5 million, but it posted a $23.7 million net loss.
Go toTop